Literature DB >> 12032732

Mutations in a protein target of the Pim-1 kinase associated with the RP9 form of autosomal dominant retinitis pigmentosa.

T Jeffrey Keen1, Matthew M Hims, Arthur B McKie, Anthony T Moore, Rob M Doran, David A Mackey, David C Mansfield, Robert F Mueller, Shomi S Bhattacharya, Alan C Bird, Alexander F Markham, Chris F Inglehearn.   

Abstract

The RP9 form of autosomal dominant retinitis pigmentosa (adRP) maps to a locus on human chromosome 7p14. We now report two different disease associated mutations in a previously unidentified human gene, the mouse orthologue of which has been characterised by its interaction with the Pim-1 oncogene. In the original linked family we identified the missense mutation H137L. A second missense mutation, D170G, was found in a single RP patient. The putative RP9 gene appears to be expressed in a wide range of tissues, but its function is unknown and a pathogenic mechanism remains to be determined.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12032732     DOI: 10.1038/sj.ejhg.5200797

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  32 in total

Review 1.  Pre-mRNA splicing and retinitis pigmentosa.

Authors:  Daniel Mordes; Xiaoyan Luo; Amar Kar; David Kuo; Lili Xu; Kazuo Fushimi; Guowu Yu; Paul Sternberg; Jane Y Wu
Journal:  Mol Vis       Date:  2006-10-26       Impact factor: 2.367

2.  Novel rhodopsin mutations and genotype-phenotype correlation in patients with autosomal dominant retinitis pigmentosa.

Authors:  A Schuster; N Weisschuh; H Jägle; D Besch; A R Janecke; H Zierler; S Tippmann; E Zrenner; B Wissinger
Journal:  Br J Ophthalmol       Date:  2005-10       Impact factor: 4.638

3.  Prevalence of disease-causing mutations in families with autosomal dominant retinitis pigmentosa: a screen of known genes in 200 families.

Authors:  Lori S Sullivan; Sara J Bowne; David G Birch; Dianna Hughbanks-Wheaton; John R Heckenlively; Richard Alan Lewis; Charles A Garcia; Richard S Ruiz; Susan H Blanton; Hope Northrup; Anisa I Gire; Robyn Seaman; Hatice Duzkale; Catherine J Spellicy; Jingya Zhu; Suma P Shankar; Stephen P Daiger
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-07       Impact factor: 4.799

4.  Dominant retinitis pigmentosa phenotype associated with a new mutation in the splicing factor PRPF31.

Authors:  S Ghazawy; K Springell; V Gauba; M A McKibbin; C F Inglehearn
Journal:  Br J Ophthalmol       Date:  2007-10       Impact factor: 4.638

Review 5.  Genetic modifiers and oligogenic inheritance.

Authors:  Maria Kousi; Nicholas Katsanis
Journal:  Cold Spring Harb Perspect Med       Date:  2015-06-01       Impact factor: 6.915

Review 6.  Evolutionary conservation and expression of human RNA-binding proteins and their role in human genetic disease.

Authors:  Stefanie Gerstberger; Markus Hafner; Manuel Ascano; Thomas Tuschl
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

Review 7.  Genetic characterization and disease mechanism of retinitis pigmentosa; current scenario.

Authors:  Muhammad Umar Ali; Muhammad Saif Ur Rahman; Jiang Cao; Ping Xi Yuan
Journal:  3 Biotech       Date:  2017-07-18       Impact factor: 2.406

8.  Mutations in SNRPE, which encodes a core protein of the spliceosome, cause autosomal-dominant hypotrichosis simplex.

Authors:  Sandra M Pasternack; Melanie Refke; Elham Paknia; Hans Christian Hennies; Thomas Franz; Niklas Schäfer; Alan Fryer; Maurice van Steensel; Elizabeth Sweeney; Miquel Just; Clemens Grimm; Roland Kruse; Carlos Ferrándiz; Markus M Nöthen; Utz Fischer; Regina C Betz
Journal:  Am J Hum Genet       Date:  2012-12-13       Impact factor: 11.025

9.  Autosomal-dominant retinitis pigmentosa caused by a mutation in SNRNP200, a gene required for unwinding of U4/U6 snRNAs.

Authors:  Chen Zhao; Deepti L Bellur; Shasha Lu; Feng Zhao; Michael A Grassi; Sara J Bowne; Lori S Sullivan; Stephen P Daiger; Li Jia Chen; Chi Pui Pang; Kanxing Zhao; Jonathan P Staley; Catharina Larsson
Journal:  Am J Hum Genet       Date:  2009-10-29       Impact factor: 11.025

10.  Evaluation of splicing efficiency in lymphoblastoid cell lines from patients with splicing-factor retinitis pigmentosa.

Authors:  Lenka Ivings; Katherine V Towns; M A Matin; Charles Taylor; Frederique Ponchel; Richard J Grainger; Rajkumar S Ramesar; David A Mackey; Chris F Inglehearn
Journal:  Mol Vis       Date:  2008-12-18       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.